USPTO serial 79270687
VALIDOGEN
Reviewed by CopyMark Law Group
Reg. 6155753Status 706Renewal
- Filing date
- Status date
- Registration date
- Sep 22, 2020
- Examiner
- CALLERY, TIMOTHY JOHN
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with VALIDOGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathon T. Reavill
Jonathon T. Reavill Nixon & Vanderhye, P.C.901 N. GLEBE ROAD11TH FLOORARLINGTON, VA 22203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological, biochemical and biotechnological preparations, namely, for scientific and commercial purposes; biochemicals, namely, microorganisms in the form of, yeast and bacteria for use in protein expression; microbial production strains, namely, Komagataella phaffii strains known as Pichia pastoris and Escherichia coli strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; [ microbial production strains for producing plasmid DNA; ] yeast strains, other than for making wine, medical or veterinary use; bacterial strains, other than for making wine, medical or veterinary use; proteins for use in science; proteins, not for scientific purposes and medical or veterinary use; proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; proteins specifically, enzymes, for use in production processes, namely, for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; proteins for industrial use in particular for industrial, analytic and diagnostic purposes and cleaning purposes; enzymes derived from biotechnological processes for industrial use; nucleic recombinant acids, in particular plasmid DNA, for laboratory use; nucleic acids, in particular deoxyribonucleic acids, in particular for protein production | ACTIVE | — |
| 042 | Consultancy, namely, providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development in the field of chemistry, biochemistry, and biotechnology; chemical and biological laboratory services; conducting of biological and biotechnological tests for commercial and scientific purposes; industrial biotechnological research; biotechnological research in the field of enzymatic synthesis; providing information on the subject of scientific research in the field of biochemistry and biotechnology; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production [ and plasmid DNA production ] ; research and development services relating to biotechnical biochemistry science; development of proteins for use in pharmaceuticals, biotechnology, and medical and veterinary diagnostics; scientific research and development services, namely, production of proteins, [ plasmid DNA production, plasmid DNA purification, ] modification of proteins, purification of proteins, DNA manipulation and cell banking services for others; development of bioprocesses for protein production [ and plasmid DNA production ] ; strain development services, namely, development of production strains for producing proteins; [ strain development, in particular the development of production strains for producing plasmid DNA; enzyme engineering for others; ] development of protein production processes for others; [ development of processes for producing plasmid DNA for others; plasmid DNA synthesis for others; development of plasmid DNA purification methods; ] development of protein purification methods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Oct 23, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Oct 19, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 22, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 22, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 22, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 22, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 20, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 22, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 14, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 14, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 14, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 9, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 9, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 22, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 22, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 17, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 5, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 5, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 14, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 31, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |